Rheumatoid Arthritis Completed Phase 2 Trials for Rituximab (DB00073)

Also known as: RA / Rheumatic Arthritis / Arthritis, Rheumatoid / Arthritis,Rheumatoid / Rheumatoid Arthritis (RA) / Rheumatoid Arthritis(RA) / Arthritis, Rheumatoid (RA) / Systemic rheumatoid arthritis / Arthritis rheumatoid / Rheumatoid arthritis, unspecified / R arthritis / Rh arthritis / Atrophic arthritis

IndicationStatusPhase
DBCOND0027961 (Rheumatoid Arthritis)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00074438Study to Assess the Efficacy and Safety of Rituximab in Patients With Rheumatoid ArthritisTreatment
NCT00282308A Study to Evaluate the Effects of Rituximab on Immune Responses in Subjects With Active Rheumatoid Arthritis Receiving Background MethotrexateTreatment
NCT00147966Assessment of Rituximab's Immunomodulatory Synovial Effects (The ARISE Study)Diagnostic
NCT00664521Atacicept in Combination With Rituximab in Subjects With Rheumatoid Arthritis (August III)Treatment
NCT02693210A Study to Evaluate the Efficacy and Safety of Mabthera Alone and in Combination With Either Cyclophosphamide or Methotrexate in Patients With Rheumatoid ArthritisTreatment
NCT00555542An Analysis of Peripheral Blood T Cell Subsets on Rheumatoid ArthritisTreatment
NCT00425932Impact of Rituximab on MRI Evidence of Disease Activity in Patients With Moderate to Severe Rheumatoid ArthritisTreatment
NCT02093026A Study to Assess the Efficacy and Safety of Retreatment With MabThera (Rituximab) in Patients With Active Rheumatoid Arthritis (RA)Treatment
NCT00243412A Study of the Safety and Efficacy of Rituximab in Patients With Moderate to Severe Rheumatoid Arthritis Receiving MethotrexateTreatment